Jul 24, 2026 07:26AM
Jul 22, 2026 07:31AM
Jul 22, 2026 07:30AM
Jun 16, 2026 06:42AM
May 27, 2026 07:30AM
May 27, 2026 07:30AM
May 7, 2026 04:01PM BridgeBio Reports First Quarter 2026 Financial Results and Corporate Updates
Mar 30, 2026 09:50AM
Feb 15, 2025 10:00PM
Dec 18, 2024 09:08AM
Nov 25, 2024 08:24AM
Nov 25, 2024 08:12AM
Nov 18, 2024 11:15AM
Nov 12, 2024 07:30AM BridgeBio Pharma Reports Third Quarter 2024 Financial Results and Business Update
Sep 30, 2024 08:25AM
Sep 27, 2024 06:00PM
Sep 11, 2024 07:40AM
Aug 30, 2024 10:50AM
Aug 30, 2024 10:50AM
Aug 2, 2024 12:19PM
Aug 1, 2024 07:30AM BridgeBio Pharma Reports Second Quarter 2024 Financial Results and Business Update
Jun 24, 2024 11:36AM
May 30, 2024 05:39AM
May 29, 2024 04:01PM
May 13, 2024 07:30AM
May 13, 2024 07:30AM
May 2, 2024 07:30AM
Apr 7, 2024 01:15PM BridgeBio Pharma Presents Cardiac Magnetic Resonance (CMR) Imaging Evidence Consistent with Clinical Improvement Observed in the ATTRibute-CM Phase 3 Study in Patients with Transthyretin Amyloid Cardi
Mar 4, 2024 02:30AM
Feb 23, 2024 12:35PM
Feb 22, 2024 07:30AM
Feb 5, 2024 07:32AM
Feb 5, 2024 07:30AM
Jan 31, 2024 03:46AM
Jan 6, 2020 07:31AM BridgeBio Pharma's (BBIO) QED Therapeutics Receives Fast Track Designation for Infigratinib in Adults with First-Line Advanced or Metastatic Cholangiocarcinoma and Orphan Drug Designation for Infigrat
Jan 6, 2020 07:30AM
Jan 6, 2020 07:30AM

15,578 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All